As co-founder and CEO of Rhino Health, Dr. Ittai Dayan is transforming the way healthcare AI solutions are created, adopted and measured. The Rhino Health Platform provides access to a large, distributed dataset from a diverse group of patients, powering models that deliver consistent results and, ultimately, improve health outcomes for large populations of patients. Drawing on his background as a clinician and researcher, Ittai is passionate about creating equitable access to advanced AI-based diagnostics and treatment pathways – across increasingly diverse patient populations. He led the EXAM study, published in Nature Medicine, which is the world’s largest and most prominent study to-date utilizing federated learning (FL) to train a healthcare AI solution on diverse data across institutions.
Prior to co-founding Rhino Health, Ittai served as an Executive Director at Mass General Brigham, where he led the Center for Clinical Data Science (CCDS). There, he oversaw development of 20+ clinical applications using AI and collaborated closely with health and technology leaders on R&D projects designed to accelerate adoption of new AI-based healthcare solutions. Previously, he held managerial roles at Boston Consulting Group, focused on go-to-market transformation for biopharma, biotech and digital health companies operating in today’s value-based healthcare ecosystem.
Ittai has studied at the Johns Hopkins Bloomberg School of Public Health. He earned his MD and his Bachelors of Science from The Hebrew University of Jerusalem. He serves on the Editorial Board of Nature Digital Medicine, a leading publisher of peer-reviewed scientific studies. His own research has been published in journals including those from Nature group, IEEE’s Journal of Biomedical and Health Informatics, and at the MICCAI conference.